186 related articles for article (PubMed ID: 25516025)
21. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
22. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
23. Delivery Characteristics, Acceptability, and Depression Outcomes of a Home-based Depression Intervention for Older African Americans: The Get Busy Get Better Program.
Gitlin LN; Harris LF; McCoy MC; Hess E; Hauck WW
Gerontologist; 2016 Oct; 56(5):956-65. PubMed ID: 26608333
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
[TBL] [Abstract][Full Text] [Related]
25. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
[TBL] [Abstract][Full Text] [Related]
26. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.
Davis JC; Liu-Ambrose T; Khan KM; Robertson MC; Marra CA
Osteoporos Int; 2012 Jul; 23(7):1849-57. PubMed ID: 21909728
[TBL] [Abstract][Full Text] [Related]
27. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
28. Cost-utility analysis of a preventive home visit program for older adults in Germany.
Brettschneider C; Luck T; Fleischer S; Roling G; Beutner K; Luppa M; Behrens J; Riedel-Heller SG; König HH
BMC Health Serv Res; 2015 Apr; 15():141. PubMed ID: 25884452
[TBL] [Abstract][Full Text] [Related]
29. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
De Salas-Cansado M; Álvarez E; Olivares JM; Carrasco JL; Ferro MB; Rejas J
Soc Psychiatry Psychiatr Epidemiol; 2013 Jun; 48(6):985-96. PubMed ID: 23086587
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community.
Hebert PL; Sisk JE; Wang JJ; Tuzzio L; Casabianca JM; Chassin MR; Horowitz C; McLaughlin MA
Ann Intern Med; 2008 Oct; 149(8):540-8. PubMed ID: 18936502
[TBL] [Abstract][Full Text] [Related]
31. Home-based medication review in older people: is it cost effective?
Pacini M; Smith RD; Wilson EC; Holland R
Pharmacoeconomics; 2007; 25(2):171-80. PubMed ID: 17249858
[TBL] [Abstract][Full Text] [Related]
32. An Occupational Therapy intervention for residents with stroke-related disabilities in UK Care Homes (OTCH): cluster randomised controlled trial with economic evaluation.
Sackley CM; Walker MF; Burton CR; Watkins CL; Mant J; Roalfe AK; Wheatley K; Sheehan B; Sharp L; Stant KE; Fletcher-Smith J; Steel K; Barton GR; Irvine L; Peryer G;
Health Technol Assess; 2016 Feb; 20(15):1-138. PubMed ID: 26927209
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
34. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain.
Jódar-Sánchez F; Martín JJ; López del Amo MP; García L; Araújo-Santos JM; Epstein D
J Am Geriatr Soc; 2014 Jul; 62(7):1272-80. PubMed ID: 24891096
[TBL] [Abstract][Full Text] [Related]
35. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
36. Cost-utility analysis of hearing aid device for older adults in the community: a delayed start study.
Kaur P; Chong SL; Kannapiran P; Teo WK; Ling CNW; Weichen CW; Ruling G; Yin LS; Leng TY; Pei SY; Kang TT; Han LZ; Peizhen L; Yee LLH; George PP
BMC Health Serv Res; 2020 Dec; 20(1):1112. PubMed ID: 33261603
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial.
Meads DM; Martin A; Griffiths A; Kelley R; Creese B; Robinson L; McDermid J; Walwyn R; Ballard C; Surr CA
Appl Health Econ Health Policy; 2020 Apr; 18(2):237-247. PubMed ID: 31701483
[TBL] [Abstract][Full Text] [Related]
38. Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial.
Charlesworth G; Shepstone L; Wilson E; Thalanany M; Mugford M; Poland F
Health Technol Assess; 2008 Mar; 12(4):iii, v-ix, 1-78. PubMed ID: 18284895
[TBL] [Abstract][Full Text] [Related]
39. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
40. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
Cross J; Elender F; Barton G; Clark A; Shepstone L; Blyth A; Bachmann M; Harvey I;
Health Technol Assess; 2010 May; 14(23):1-147, iii-iv. PubMed ID: 20487638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
